Kidney /renal Function Test Market Worth 790.1 Mn Usd by 2022

Friday 22 December 2017, Amsterdam

Market Research Report Press Release

The report is now available on ASDreports,"Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022", The global kidney/renal function test market is expected to reach USD 790.1 Million by 2022 from an estimated USD 586.5 Million in 2017, at a CAGR of 6.1%. The key factors driving the growth of this market include the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and rise in alcohol consumption.


By product, the dipsticks segment is expected to dominate the market in 2017

By product, the market is categorized into dipsticks, reagents, and disposables. Dipsticks are expected to account for the largest share of the market in 2017, they are also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the cost-effectiveness of dipstick testing and its widespread applications across specializations.

By type, the urine tests segment is expected to account for the largest share of the market in 2017

Based on type, the market is segmented into urine and blood tests. Urine tests are further categorized into urine protein, creatinine clearance, and microalbumin. Similarly, blood tests are categorized into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN).

In 2017, the urine tests segment is expected to account for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. Factors contributing to the large share and high growth rate of this segment include increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood samples, and this method also has a very limited risk of infection.

North America to dominate the market in 2017

North America is expected to account for the largest share of the global kidney function/renal function test market. The large share of the North American market is attributed to the increasing incidence of chronic diseases, rising prevalence of hypertension, growing incidence of diabetes in the US, and increasing initiatives by the Canadian government for the treatment of kidney diseases.

The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).
Kidney/Renal Function Test Market -Global Forecast to 2022

Kidney/Renal Function Test Market -Global Forecast to 2022

Publish date : December 2017
Report code : ASDR-435035
Pages : 128

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News